HISTORY >

Leaders in Monolith Separation Technology

BIA Separations is the only worldwide manufacturer of Short Monolithic Columns optimized to meet the research and production needs of the biotechnology industry. The company is headquartered in Villach, Austria and currently has two subsidiaries: Slovenian subsidiary, located in Ljubljana, consists of Research & Development as well as Production facilities and a sales office located in Wilmington, Delaware (US).

BIA Separations was founded by a group of scientists and venture capital investors whose purpose is to become leaders in innovative liquid chromatographic methods and develop monolithic materials for the next century. Based on more than 10 years of experience, BIA Separations has developed a wide range of CIM Convective Interaction Media® that address the growing need for timesaving innovations in therapeutic biomolecule purification. Through both internal initiatives and external collaborations, this ISO certified company pursues the highest quality standards in its research, development, production, and customer service efforts. Additionally, the company uses its expertise in liquid chromatography to develop and validate analytical methods and design industrial purification processes. The people of BIA Separations are committed to providing customers the most reproducible and innovative products to meet their current and future separation needs.

Company Milestones

2011 BIA Separations receives KAPPA-Health Award for being a model research intensive SME in EU Co-funded projects
2011 Analytical Contract Research Laboratory was approved by Agency for Medicinal Products and Medical Devices of the Republic Slovenia and is now the holder of laboratory quality control authorization according to EU GMP Volume 4, Chapter 7 – Contract Manufacture and Analysis.
2010 CIM® SO3 Monolithic Supports receive Drug Master File
2009 Pass second FDA audit for one of the projects
2008
Partnership with Agilent Technologies – develop and produce analytical monolithic columns
2006
First cGMP production of a vaccine (influenza) using CIM®
2006 CIM® QA Monolithic Supports receive Drug Master File Number (19695)
2004 5th Anniversary of BIA Separations
2003 ISO 9001:2000 Certification (Q-579)
2002 CIM® DEAE Monolithic Supports receive Drug Master File Number (15838)
Analytical Lab Passes FDA Inspection
2001 BIA Separations and Boehringer Ingelheim announce cooperation in pDNA Manufacturing
1998 BIA Separations Founded

Subscribe to our newsletter:

Subscribe
Unsubscribe